Efficacy and safety of AZD7594, an inhaled non-steroidal selective glucocorticoid receptor modulator, in patients with asthma: a phase 2a randomized, double blind, placebo-controlled crossover trial

BACKGROUND: Inhaled corticosteroids reduce inflammation in asthma but chronic use may cause adverse effects. AZD7594, an inhaled non-steroidal selective glucocorticoid receptor modulator, has the potential of an improved risk-benefit profile. We investigated the safety and efficacy of AZD7594 in ast...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Mary N., Fuhr, Rainard, Beier, Jutta, Su, Hong-Lin, Chen, Yingxue, Forsman, Henrik, Hamrén, Ulrika Wählby, Jackson, Helen, Aggarwal, Ajay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380015/
https://www.ncbi.nlm.nih.gov/pubmed/30777086
http://dx.doi.org/10.1186/s12931-019-1000-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6380015/
https://www.ncbi.nlm.nih.gov/pubmed/30777086
http://dx.doi.org/10.1186/s12931-019-1000-7

Ejemplares similares